Citing medical officials, the paper said "Jin Hua" was picked from among more than 100 classic anti-flu prescriptions based on traditional Chinese herbal medicine.
"Science workers proved its effectiveness through medical experiments on more than 4,000 mice and clinical studies on 410 patients with slight A/H1N1 flu syndrome," it said.
The "Jin Hua" prescription had been adopted in many local traditional Chinese medicine hospitals, it said.
Zhao Jing said 11 hospitals nationwide, including Chaoyang Hospital and Ditan Hospital in Beijing, had conducted clinical studies on "Jin Hua" and gave positive assessments.
"We are applying for patents for 'Jin Hua' both at home and abroad," she said.
"We are further developing the medicine and trying to present it to the whole country and world as soon as possible, thus offering an alternative to treat the A/H1N1 flu," she said.
The Chinese mainland has reported almost 108,000 A/H1N1 flu cases, including 442 deaths, according to the Ministry of Health.
Dr. Cris Tunon, senior program management officer at the WHO Representative Office in China, said Thursday the "WHO welcomes the clinical results," as the traditional Chinese medicine offered a low-cost treatment of A/H1N1 flu.
"Science workers proved its effectiveness through medical experiments on more than 4,000 mice and clinical studies on 410 patients with slight A/H1N1 flu syndrome," it said.
The "Jin Hua" prescription had been adopted in many local traditional Chinese medicine hospitals, it said.
Zhao Jing said 11 hospitals nationwide, including Chaoyang Hospital and Ditan Hospital in Beijing, had conducted clinical studies on "Jin Hua" and gave positive assessments.
"We are applying for patents for 'Jin Hua' both at home and abroad," she said.
"We are further developing the medicine and trying to present it to the whole country and world as soon as possible, thus offering an alternative to treat the A/H1N1 flu," she said.
The Chinese mainland has reported almost 108,000 A/H1N1 flu cases, including 442 deaths, according to the Ministry of Health.
Dr. Cris Tunon, senior program management officer at the WHO Representative Office in China, said Thursday the "WHO welcomes the clinical results," as the traditional Chinese medicine offered a low-cost treatment of A/H1N1 flu.